US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Transgene SA (0OCQ) 銘柄情報

Transgene SA (0OCQ)

3.04

0.00

( 0.00% )

更新日時： 09:00:00

Transgene SA (0OCQ) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

3.04

( - )

買値

3.04

売値

3.04

出来高

600

0.00 日の範囲 0.00

3.04 52 週間の範囲 3.04

時価総額

前日終値

3.04

始値

-

時刻

最終取引時間

16:46:24

財務取引量

-

VWAP

-

平均取引量 (3 か月)

41,661 €

発行済株式数

273,882,230

配当利回り

PER

-2.81

1 株当たり利益 (EPS)

-0.26

歳入

7.21M

純利益

-37.52M

Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase II clinical trial for the treatment of head and neck cancers; TG4001, a therapeutic v... Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase II clinical trial for the treatment of head and neck cancers; TG4001, a therapeutic vaccine, which is in Phase II clinical trial for the treatment of human papillomavirus (HPV 16) positive cancers; and BT-001, an oncolytic virus, which is in Phase I/II clinical trial for the treatment of solid tumors. The company also develops TG6050 for the treatment of non-small cell lung cancer that is in Phase 1 clinical trial. It has strategic collaboration agreements with NEC Corporation and NEC Bio, BioInvent, Merck & Co., Inc., Oxford Biomedica, Stamford, SillaJen, and ProBioGen. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.transgene.com

本社

Illkirch-graffenstaden, France

設立

1979

Transgene SA is listed in the sector of the ロンドン証券取引所 with ticker 0OCQ. The last closing price for Transgene was 3.04 €. Over the last year, Transgene shares have traded in a share price range of 3.04 € to 3.04 €.

Transgene currently has 273,882,230 shares in issue. The market capitalisation of Transgene is 832.60 € million. Transgene has a price to earnings ratio (PE ratio) of -2.81.

Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate (TG MVA(TM)) at WCID 2026

Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate...

Transgene présente des données précliniques de son vaccin innovant contre le mpox produit sur lignée cellulaire, TG-MVA

Transgene présente des données précliniques de son vaccin innovant contre le mpox produit sur lignée cellulaire, TG-MVA Basé sur un vecteur viral...

Transgene étend sa plateforme myvac® avec TG4070, un vaccin thérapeutique individualisé dans le cancer du poumon non à petites cellules

Transgene étend sa plateforme myvac® avec TG4070, un vaccin thérapeutique individualisé dans le cancer du poumon non à petites cellules Associant...

Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine

Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine Combining cutting-edge...

Transgene to Present Preclinical Data on Novel TG-MVA Prophylactic Vaccine Against mpox at the World Congress on Infectious Diseases

Transgene to Present Preclinical Data on Novel TG-MVA Prophylactic Vaccine Against mpox at the World Congress on Infectious Diseases TG-MVA builds...

Transgene présente des résultats précliniques avec TG-MVA, un nouveau vaccin prophylactique contre la variole du singe (mpox), au Congrès mondial sur les maladies infectieuses

Transgene présente des résultats précliniques avec TG-MVA, un nouveau vaccin prophylactique contre la variole du singe (mpox), au Congrès mondial...

Transgene’s Combined General Meeting of May 22, 2026

Transgene’s Combined General Meeting of May 22, 2026 Strasbourg, France, May 22, 2026, 5:45 p.m. CET – The Combined Ordinary and Extraordinary...

Assemblée Générale Mixte de Transgene du 22 mai 2026

Assemblée Générale Mixte de Transgene du 22 mai 2026 Strasbourg, France, le 22 mai 2026, 17 h 45 – L’Assemblée Générale Mixte (ordinaire et...

Mise à disposition des documents préparatoires à l'Assemblée générale du 22 mai 2026

Mise à disposition des documents préparatoires à l'Assemblée générale du 22 mai 2026 Strasbourg, France, le 4 mai 2026, 17 h 45 – Transgene...

Availability of Preparatory Documents for the Combined General Meeting of May 22, 2026

Availability of Preparatory Documents for the Combined General Meeting of May 22, 2026 Strasbourg, France, May 4, 2026, 5:45 p.m. CET – Transgene...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	3.04	3.04	3.04	934	3.04	DE
52	0	0	3.04	3.04	3.04	1519	3.04	DE
156	0	0	3.04	3.04	3.04	539	3.04	DE
260	0	0	3.04	3.04	3.04	748	3.04	DE

0OCQ - Frequently Asked Questions (FAQ)

What is the current Transgene SA share price?

The current share price of Transgene SA is 3.04 €

How many Transgene SA shares are in issue?

Transgene SA has 273,882,230 shares in issue

What is the market cap of Transgene SA?

The market capitalisation of Transgene SA is EUR 832.6M

What is the 1 year trading range for Transgene SA share price?

Transgene SA has traded in the range of 3.04 € to 3.04 € during the past year

What is the PE ratio of Transgene SA?

The price to earnings ratio of Transgene SA is -2.81

What is the cash to sales ratio of Transgene SA?

The cash to sales ratio of Transgene SA is 27.77

What is the registered address of Transgene SA?

The registered address for Transgene SA is 400, boulevard Gonthier d’Andernach, Illkirch-Graffenstaden, Alsace, 67405

What is the Transgene SA website address?

The website address for Transgene SA is www.transgene.com

Implanting

Implanting 2分前

Here's a good Micheal Pento interview from yesterday. He speaks to what he sees Warsh and the Fed doing, which will be lowering rates, most likely.
Pento likes gold and the gold miners down here as very beatdown and undervalued. I think we can all agree with that logic.

I agree

Madguppy

Madguppy 2分前

https://x.com/KEYSCANE/status/2072847165278335453?s=20

Madguppy

Madguppy 2分前

https://x.com/skies_bluebird/status/2073011857288307009?s=20

mauiguy2

mauiguy2 4分前

A word of caution, Brodey......nothing is gained if you're tossed in I-Hub jail for an extended period. It might be wise to tamper things down a bit, especially since you're already limited to just one post per day.

PickStocks

PickStocks 6分前

Yes….but WMI/WMB only received millions not the billions predicted……what did the FDIC do with the money….,maybe not enough to distribute but pay off Accounting fees..

brazen22

brazen22 6分前

You’ve been waiting years for approval?

Maybe it’s not me that’s on something.

berigud

berigud 10分前

You and the other boosters have been telling us for 2 decades, just listen to the company news. Believe what they say. Total BS. None have come true. Go back a decade or 2 on this message board and read your and others old post supporting the Riccelli's. NOT ONE HAS COME TRUE. It is all there

SovereignNinja5

SovereignNinja5 10分前

Amarin was removed from the NASDAQ Biotechnology Index on December 18, 2025, which directly removed it from IBB.
Re-entry into the NASDAQ Biotechnology Index (IBB) requires meeting and sustaining:
• Minimum market capitalization of $200 million
• Average daily trading volume o

justhefax

justhefax 12分前

yes, and could be in for a manufactured pop. But the dream is the new co that is featured and serious... and looking to build real lasting value.
But only 20%, and no understanding about their values, and team all remains uncertain.
If we see substantial new dilution , the current sel

CA Market News

CA Market News 12分前

Guanajuato Silver Announces AGM ResultsJuly 3, 2026 7:30 AM
ACCESS NewswireVANCOUVER, BC / ACCESS Newswire / July 3, 2026 / Guanajuato Silver Company Ltd. (the "Company"

US Market News

US Market News 13分前

PSE&G Urges Customers To Prepare for Continued Extreme Heat and Potential Thunderstorms Through the Holiday WeekendJuly 3, 2026 7:30 AM
PR Newswire (US) class="legendSpanClass"NEWARK, N.J., class="legendSpanClass"July 3, 2026 /PRNewswire

CA Market News

CA Market News 13分前

Nine Mile Metals Strengthens Capital Markets Strategy with Market-Making and Global Digital Media EngagementsJuly 3, 2026 7:41 AM
Newsfile

bubba412

bubba412 15分前

If they do a 15 to 1 reverse and the stock pps is 10 dollars you’ll be losing money

Wallstreeter$$$

Wallstreeter$$$ 15分前

If they had to respond to 40 reviewers as u claim, so what!? You assume thats a bad thing and not just part of the stringent process cuz Radiogel is a radioactive treatment so I would hope they'd go thru the sub with a fine tooth comb. But as u said its your opinion and we all know how much that's w

Lifetime

Lifetime 15分前

That is John Ellis not Einstein, Einstein.

brazen22

brazen22 18分前

It’s easy to tell when a post landed. Otherwise, the incoming would be rebuttals, not sophomoric cheap shots

chazzy1

chazzy1 22分前

"Definitions and explanations generated entirely by AI are not copyrightable. Under U.S. copyright law, a work must have human authorship to receive protection. If an AI tool writes the definitions for you, they enter the public domain and anyone can copy them freely."
Thus I have no concerns

GoodGuyBill

GoodGuyBill 24分前

Sage007, you can call my prior post “cow dung” all you want, but facts don’t disappear because you refuse to read them. Here is a clean, structured list of NWBO’s accomplishments and MHRA accommodations over the last three years — each with what it is and why it matters-- that you ignore or believe

mauiguy2

mauiguy2 26分前

They're promising us less than they promised back in 2022.

Good Day LuLa!

Since you've been a solid backer of CYB for many years, I was a bit surprised to read your unhappiness regarding the welcomed shareholder letter.

I can give you 2 credible reasons

Idunno

Idunno 27分前

Or, is it something else?

CA Market News

CA Market News 28分前

Founders Metals Appoints Felicia de la Paz as Chief Financial OfficerJuly 3, 2026 7:00 AM
NewsfileVancouver, British Columbia--(Newsfil

I am done

I am done 29分前

$BSAI BluSky AI Inc. Team building with the Appointment of Mort Aaronson to Board of Directors
https://www.globenewswire.com/news-release/2026/07/01/3320731/29006/en/BluSky-AI-Inc-Announces-Appointment-of-Mort-Aaronson-to-Board-of-Directors.html

Carome

Carome 29分前

I fell for a complex options strategy from a YouTube guru. I didn’t understand pin risk or early assignment, and I lost £2,800 when a spread went wrong. Laura G. Prescott on Facebook simplified everything: she taught me covered calls on stocks I already owned. She personally helped me pick the first

I am done

I am done 30分前

$BSAI BluSky AI Inc. Team building with the Appointment of Mort Aaronson to Board of Directors
https://www.globenewswire.com/news-release/2026/07/01/3320731/29006/en/BluSky-AI-Inc-Announces-Appointment-of-Mort-Aaronson-to-Board-of-Directors.html

Idunno

Idunno 33分前

Are you really on a high school debate club?

United Therapeutics

Kingfisher Mining

CI Global Minimum Downsi...

Commonwealth Bank of Aus...

Jones Soda (QB)

New Century Resources

Westpac Banking

IShares MSCI Germany

Blue Star Helium

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。